Are you Dr. Feany?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis Street Amory 3
Brigham And Womens Hospital Department Of Pathology
Boston, MA 02115Phone+1 617-732-7510- Is this information wrong?
Summary
- Dr. Mel Feany, MD is a board certified pathologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Brigham and Women's Hospital and is a Professor at Harvard Medical School.
Education & Training
- Brigham and Women's HospitalFellowship, Neuropathology, 1997 - 1999
- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
- Albert Einstein College of MedicineClass of 1995
Certifications & Licensure
- MA State Medical License 1999 - 2025
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in aknock-in tauopathy model.Vanitha Nithianadam, Rachel A Battaglia, Anthony Cicalo, Souvarish Sarkar, Aram Comjean, Yanhui Hu, Matthew J Leventhal, Xianjun Dong, Hassan Bukhari, Mel B Feany> ;Genome Research. 2024 Apr 10
- A systems-biology approach connects aging mechanisms with Alzheimer's disease pathogenesis.Matthew J Leventhal, Camila A Zanella, Byunguk Kang, Jiajie Peng, David Gritsch, Zhixiang Liao, Hassan Bukhari, Tao Wang, Ping-Chieh Pao, Serwah Danquah, Joseph Beneta...> ;Biorxiv. 2024 Mar 17
- Deep sequencing of proteotoxicity modifier genes uncovers a Presenilin-2/beta-amyloid-actin genetic risk module shared among alpha-synucleinopathies.Sumaiya Nazeen, Xinyuan Wang, Dina Zielinski, Isabel Lam, Erinc Hallacli, Ping Xu, Elizabeth Ethier, Ronya Strom, Camila A Zanella, Vanitha Nithianandam, Dylan Ritter,...> ;Biorxiv. 2024 Mar 7
- Join now to see all
Press Mentions
- Cross-Species Strategy Might Be a Powerful Tool for Studying Human DiseaseFebruary 4th, 2011
- New Parkinson’s Research Center to Open at YaleNovember 4th, 2023
Grant Support
- Pharmacological Modulation Of TAU Neurotoxicity In VivoNational Institute On Aging2011
- Mechanisms Underlying Neuronal Cell Type Specificity In NeurodegenerationNational Institute On Aging2008–2011
- Chemical Modulation Of Lysosomal Storage In VivoNational Institute Of Neurological Disorders And Stroke2009–2010
- Drosophila Models Of Alexander DiseaseNational Institute Of Neurological Disorders And Stroke2008–2009
- Phosphorylation Control Of TAU Neurotoxicity In DrosophilaNational Institute On Aging2007–2008
- Aging In Drosophila Models Of Human NeurodegenerationNational Institute On Aging2006–2007
- Drosophila Model Of Amyotrophic Lateral SclerosisNational Institute Of Neurological Disorders And Stroke2004–2007
- Phosphorylation Control--Tau Neurotoxicity In DrosophilaNational Institute On Aging2004–2006
- Genetic Dissection Of Neurodegenerative DementiasNational Institute On Aging2001–2005
- Drosophila Model Of Parkinson'S DiseaseNational Institute Of Neurological Disorders And Stroke2001–2005
- Genetic Model Of NeurodegenerationNational Institute On Aging1998–2003
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts